Coherus Biosciences Stock Price Prediction
| CHRS Stock | USD 1.21 0.12 11.01% |
Oversold Vs Overbought
46
Oversold | Overbought |
Quarterly Earnings Growth (0.76) | EPS Estimate Next Quarter (0.07) | EPS Estimate Current Year (1.00) | EPS Estimate Next Year (0) | Wall Street Target Price 6.5 |
Using Coherus BioSciences hype-based prediction, you can estimate the value of Coherus BioSciences from the perspective of Coherus BioSciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Coherus BioSciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Coherus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Coherus BioSciences after-hype prediction price | USD 1.21 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Coherus |
Coherus BioSciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Coherus BioSciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Coherus BioSciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Coherus BioSciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Coherus BioSciences Estimiated After-Hype Price Volatility
In the context of predicting Coherus BioSciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Coherus BioSciences' historical news coverage. Coherus BioSciences' after-hype downside and upside margins for the prediction period are 0.06 and 7.82, respectively. We have considered Coherus BioSciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Coherus BioSciences is very risky at this time. Analysis and calculation of next after-hype price of Coherus BioSciences is based on 3 months time horizon.
Coherus BioSciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Coherus BioSciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Coherus BioSciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Coherus BioSciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.02 | 6.61 | 0.00 | 0.00 | 5 Events / Month | 7 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.21 | 1.21 | 0.00 |
|
Coherus BioSciences Hype Timeline
Coherus BioSciences is currently traded for 1.21. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Coherus is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.02%. %. The volatility of related hype on Coherus BioSciences is about 3177.88%, with the expected price after the next announcement by competition of 1.21. About 70.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.09. Coherus BioSciences last dividend was issued on the June 26, 1995. The entity had 2:1 split on the December 8, 1992. Given the investment horizon of 90 days the next projected press release will be in about 5 days. Check out Coherus BioSciences Basic Forecasting Models to cross-verify your projections.Coherus BioSciences Related Hype Analysis
Having access to credible news sources related to Coherus BioSciences' direct competition is more important than ever and may enhance your ability to predict Coherus BioSciences' future price movements. Getting to know how Coherus BioSciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Coherus BioSciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ASMB | Assembly Biosciences | (0.32) | 5 per month | 4.40 | (0.01) | 8.49 | (5.34) | 24.80 | |
| SPRO | Spero Therapeutics | 0.01 | 9 per month | 0.00 | (0.15) | 3.79 | (4.58) | 14.92 | |
| ACHL | Achilles Therapeutics PLC | (0.03) | 4 per month | 1.55 | 0.11 | 3.06 | (2.88) | 38.16 | |
| TIL | Instil Bio | (1.77) | 9 per month | 6.84 | 0.12 | 20.63 | (10.89) | 105.83 | |
| NLTX | Neoleukin Therapeutics | (0.14) | 1 per month | 0.00 | (0.08) | 4.05 | (3.53) | 27.84 | |
| NXTC | NextCure | (0.06) | 5 per month | 0.00 | (0.14) | 5.22 | (6.37) | 21.68 | |
| NUVB | Nuvation Bio | 0.21 | 8 per month | 4.59 | (0) | 9.48 | (8.36) | 21.30 | |
| CTMX | CytomX Therapeutics | (0.01) | 10 per month | 0.00 | (0.12) | 5.36 | (5.22) | 20.61 | |
| BOLT | Bolt Biotherapeutics | 0.03 | 8 per month | 0.00 | (0.13) | 4.76 | (4.48) | 14.96 | |
| GRCL | Gracell Biotechnologies | 0.00 | 0 per month | 6.35 | 0.16 | 16.34 | (6.25) | 52.11 |
Coherus BioSciences Additional Predictive Modules
Most predictive techniques to examine Coherus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Coherus using various technical indicators. When you analyze Coherus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Coherus BioSciences Predictive Indicators
The successful prediction of Coherus BioSciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Coherus BioSciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Coherus BioSciences based on analysis of Coherus BioSciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Coherus BioSciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Coherus BioSciences's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 10.88 | 12.95 | 10.81 | 12.85 | Receivables Turnover | 2.65 | 1.92 | 0.99 | 0.94 |
Story Coverage note for Coherus BioSciences
The number of cover stories for Coherus BioSciences depends on current market conditions and Coherus BioSciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Coherus BioSciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Coherus BioSciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Coherus BioSciences Short Properties
Coherus BioSciences' future price predictability will typically decrease when Coherus BioSciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Coherus BioSciences often depends not only on the future outlook of the potential Coherus BioSciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Coherus BioSciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 94.2 M | |
| Cash And Short Term Investments | 117.7 M |
Additional Tools for Coherus Stock Analysis
When running Coherus BioSciences' price analysis, check to measure Coherus BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coherus BioSciences is operating at the current time. Most of Coherus BioSciences' value examination focuses on studying past and present price action to predict the probability of Coherus BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coherus BioSciences' price. Additionally, you may evaluate how the addition of Coherus BioSciences to your portfolios can decrease your overall portfolio volatility.